These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25636188)

  • 1. A meta-analysis of efficacy and safety of doripenem for treating bacterial infections.
    Qu XY; Hu TT; Zhou W
    Braz J Infect Dis; 2015; 19(2):156-62. PubMed ID: 25636188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials.
    Jenkins SG; Fisher AC; Peterson JA; Nicholson SC; Kaniga K
    Curr Med Res Opin; 2009 Dec; 25(12):3029-36. PubMed ID: 19849650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Doripenem: need for a new carbapenem].
    Guery BP
    Med Mal Infect; 2009 Dec; 39(12):871-6. PubMed ID: 19875257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia.
    Cannavino CR; Castaneda-Ruiz B; Redman R; Go O; Cirillo I; Barauskas V; Senatorova G; Emeryk A; Bradley JS
    Pediatr Infect Dis J; 2015 Nov; 34(11):1264-7. PubMed ID: 26226440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy and Safety of Doripenem in the Treatment of Acute Bacterial Infections-A Systemic Review and Meta-Analysis of Randomized Controlled Trials.
    Lai CC; Cheng IL; Chen YH; Tang HJ
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31269697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of non-polymyxin antibiotics against nosocomial pneumonia, complicated intra-abdominal infection, or complicated urinary tract infection: A network meta-analysis of randomised clinical trials.
    Lin MH; Shen YC; Cheng HY; Teng CK; Chen WC; Lin YC; Hung CC
    J Glob Antimicrob Resist; 2023 Sep; 34():46-58. PubMed ID: 37328062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.
    Réa-Neto A; Niederman M; Lobo SM; Schroeder E; Lee M; Kaniga K; Ketter N; Prokocimer P; Friedland I
    Curr Med Res Opin; 2008 Jul; 24(7):2113-26. PubMed ID: 18549664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doripenem: a review of its use in the treatment of bacterial infections.
    Keam SJ
    Drugs; 2008; 68(14):2021-57. PubMed ID: 18778123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study).
    Mustafa M; Chan WM; Lee C; Harijanto E; Loo CM; Van Kinh N; Anh ND; Garcia J
    Int J Antimicrob Agents; 2014 Apr; 43(4):353-60. PubMed ID: 24636429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of intravenous infusion of doripenem.
    Redman R; File TM
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S28-35. PubMed ID: 19619019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
    Chastre J; Wunderink R; Prokocimer P; Lee M; Kaniga K; Friedland I
    Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative review of the carbapenems.
    Zhanel GG; Wiebe R; Dilay L; Thomson K; Rubinstein E; Hoban DJ; Noreddin AM; Karlowsky JA
    Drugs; 2007; 67(7):1027-52. PubMed ID: 17488146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator.
    Tazuma S; Igarashi Y; Inui K; Ohara H; Tsuyuguchi T; Ryozawa S;
    J Gastroenterol; 2015 Feb; 50(2):221-9. PubMed ID: 24795092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doripenem (Doribax)--a new parenteral carbapenem.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5-7. PubMed ID: 18219262
    [No Abstract]   [Full Text] [Related]  

  • 16. Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program.
    Wagenlehner FM; Sobel JD; Newell P; Armstrong J; Huang X; Stone GG; Yates K; Gasink LB
    Clin Infect Dis; 2016 Sep; 63(6):754-762. PubMed ID: 27313268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
    Rice DA; Kaniga K; Lee M; Redman R
    Int J Antimicrob Agents; 2013 Apr; 41(4):388-92. PubMed ID: 23410792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doripenem: position in clinical practice.
    Dedhia HV; McKnight R
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of seizure-inducing potential of doripenem.
    Zhanel GG; Ketter N; Rubinstein E; Friedland I; Redman R
    Drug Saf; 2009; 32(9):709-16. PubMed ID: 19670912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.